Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining-AI)
Launched by AHEPA UNIVERSITY HOSPITAL · Dec 15, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The CardioMining-AI trial is studying how artificial intelligence (AI) and machine learning can help doctors and researchers quickly and accurately analyze large amounts of medical data from electronic health records. By developing smart computer programs, the goal is to make it easier to understand important health information that can improve patient care in cardiology.
This trial is open to hospitalized patients in cardiology departments in Greece, specifically those whose medical records are stored electronically. Unfortunately, patients who have passed away during their hospital stay are not eligible to participate. If you or a family member qualifies for this study, you can expect to help advance the use of technology in healthcare, making it more efficient for doctors to access and use patient information. Your involvement could contribute to better health outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospitalised patients in Cardiology Departments in Greece
- • Patients whose medical records are electronically stored in each hospital's computer/information systems
- Exclusion Criteria:
- • Patients that died during hospitalization, and thus no discharge letter was issued
About Ahepa University Hospital
AHEPA University Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. Affiliated with the Aristotle University of Thessaloniki, the hospital combines cutting-edge facilities with a commitment to patient-centered care. AHEPA University Hospital focuses on a broad spectrum of medical disciplines, fostering collaboration among multidisciplinary teams to enhance treatment protocols and improve patient outcomes. By prioritizing ethical standards and scientific rigor, the hospital aims to contribute significantly to the development of new therapeutic options and the enhancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandroupoli, , Greece
Athens, , Greece
Heraklion, , Greece
Ioannina, , Greece
Larissa, , Greece
Patras, , Greece
Thessaloniki, , Greece
Thessaloniki, , Greece
Thessaloníki, , Greece
Thessaloníki, , Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials